drugset / Trial / NCT01016509

Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis

NCT01016509

RandomizedParallel-groupOpen-labelTreatment

Summary

A multicentric study will evaluate whether peri-procedural tight glycemic control during angioplasty revascularization for acute coronary syndrome (ACS) reduces circulating inflammatory cytokines and thrombus formation in hyperglycaemic patients. Moreover, the investigators will assess whether the tight glycemic control during the first month from coronary event reduces the incidence of coronary stent restenosis at 6-months from PCI.

Timeline

Start
2009-12
Primary completion
2010-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 50 iu Subcutaneous

Indications